TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Total Assets

Annual figures by fiscal year, from SEC filings.

2009: $741.20M2010: $1.09B2011: $1.32B2012: $2.08B2013: $2.95B2014: $3.84B2015: $5.61B2016: $6.97B2017: $8.76B2018: $11.73B2019: $14.81B2020: $17.16B2021: $25.43B2022: $29.21B2023: $33.08B2024: $37.76B2025: $40.56B$40.56B
2009Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$40.56B+7.4%
2024$37.76B+14.1%
2023$33.08B+13.2%
2022$29.21B+14.9%
2021$25.43B+48.2%
2020$17.16B+15.9%
2019$14.81B+26.2%
2018$11.73B+33.9%
2017$8.76B+25.7%
2016$6.97B+24.3%
2015$5.61B+46.2%
2014$3.84B+30.0%
2013$2.95B+41.8%
2012$2.08B+57.2%
2011$1.32B+21.5%
2010$1.09B+47.0%
2009$741.20M—